Table 1_High-dose accelerated intermittent theta burst stimulation targeting the primary m

A randomized controlled trial of 36 patients with cerebral small vessel disease (CSVD) conducted by Xiao-Ying Zhao, published on figshare in 2026. The study investigates the efficacy of high-dose accelerated intermittent theta burst stimulation (aiTBS) targeting the primary motor cortex on gait and cognitive functions. Data includes primary and secondary outcome measures assessed at baseline, post-intervention, and a 4-week follow-up.

Use Cases

• Analyzing the effect of aiTBS on gait speed based on the 3-meter Timed Up and Go (3mTUG) duration.
• Evaluating changes in cognitive function based on scores from the Chinese Mini-Mental State Examination (CMMS) and Montreal Cognitive Assessment (MoCA).
• Investigating the relationship between neuromodulation response and neuroimaging features based on the total CSVD burden score and white matter hyperintensity.
• Comparing multidimensional functional outcomes between real and sham stimulation groups based on the Tinetti Performance-Oriented Mobility Assessment score.

Strengths

• Randomized controlled trial design with real (n=19) and sham (n=17) groups.
• Multidimensional assessment includes gait, cognitive, affective, and autonomic nervous function outcomes.
• Includes a 4-week follow-up evaluation to assess sustained effects.
• Data is licensed under CC-BY-4.0 for open sharing and reuse.

Limitations

• Dataset size is very small at 26.2 KB, indicating limited scope.
• Row count and column-level documentation are unknown, requiring manual inspection after download.
• The primary data file is a DOCX document, which may require parsing to extract structured data.

Provenance

Source

figshare

Collection Method

Data collected from a randomized, single-blind, sham-controlled clinical trial.

Freshness

Last updated 2026-06-01 05:24:45.